Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by barack


T.QTRH

RE:RE:RE:background document on lawsuit

Endless appeals do have an end Meanwhile, Apple has finally settled the...

August 3, 2018

T.QTRH

RE:RE:background document on lawsuit

https://appleinsider.com/articles/18/08/01/apple-ordered-to-pay-wilan-145m...

August 3, 2018

T.CPH

RE:RE:RE:Anyone know why CPH.TO is getting hit so hard? Thanks.

  At this point they should consider selling there portion of  ...

June 6, 2018

T.CPH

RE:RE:RE:Trulance

Tenapanor FDA-NDA submission will be sent in 2nd half of this year. https...

April 25, 2018

T.CPH

RE:RE:RE:Ranbaxy Absorica promotion again in 2018 ?

“While we are disappointed that FQ118 financial data is poised to be so...

April 24, 2018

T.CPH

RE:RE:Ranbaxy Absorica promotion again in 2018 ?

https://www.cantechletter.com/2018/04/cipher-pharmaceutical-has-112-per-cent...

April 24, 2018

T.CPH

RE:RE:RE:RE:RE:Buying opportunity

 HLS stock which has the identical situation with Absorica revenue and...

April 24, 2018

T.CPH

RE:Over reaction

It’s interesting that HLS is down 6.5% and CPH is down 21%. Both have equal...

April 23, 2018

T.CPH

RE:RE:RE:RE:Revenue collapses

12% Absorica market share in the US should be what the market should expect...

April 23, 2018

T.CPH

RE:RE:RE:Revenue collapses

No doubt The promotional campaign turned out to be a disaster. Rx levels are...

April 23, 2018

T.CPH

RE:Revenue collapses

Analysts had to know Absorica revenue was going to go down. It was clearly...

April 23, 2018

T.CPH

RE:Above $5 and still very undervalued

 RX sells there lead product feraMax internationally.

April 18, 2018

T.CPH

RE:RE:RE:Huge Day

http://www.stockhouse.com/news/press-releases/2018/04/17/cardiome-completes...

April 17, 2018

T.CPH

RE:RE:RE:New March/18 Coverage Has $10 Target

http://www.stockhouse.com/news/press-releases/2018/04/12/cardiome-announces...

April 12, 2018

T.CPH

RE:RE:New March/18 Coverage Has $10 Target

https://www.cantechletter.com/2018/04/cipher-pharmaceuticals-has-a-big-upside...

April 9, 2018

T.CPH

RE:RE:Trevyent has huge potential

http://www.stockhouse.com/news/press-releases/2018/04/02/cardiome-highlights...

April 2, 2018

T.CPH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Why Is CPH trading at Just $4 ?

 That would be yuge!! epuris was $1.1 million of the $1.5 million of...

March 29, 2018

T.CPH

RE:RE:RE:RE:Why Is CPH trading at Just $4 ?

 It might be due to: Looking at the operational results in more detail,...

March 28, 2018

V.BRM

RE:RE:great undervalued green future stock !!

 huge bid at 40 cents

March 27, 2018

V.BRM

RE:great undervalued green future stock !!

Fully diluted o/s is ~ 40 million stockhouse has an inaccurate market cap. ...

March 27, 2018

Featured Company